Serum SALL4 Is a Novel Prognosis Biomarker with Tumor Recurrence and Poor Survival of Patients in Hepatocellular Carcinoma

Aim. Sal-like protein 4 (SALL4), is reexpressed in tissues of a subgroup of HCC associated with poor prognosis. Reports of SALL4 serological levels linked to HCC patients are meager and unclear in the prognosis of this malignancy. Methods. Immunohistochemistry and optical microscopy protocols were u...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Han, Su-xia, Wang, Jun-lan, Guo, Xi-jing, He, Chen-chen, Ying, Xia, Ma, Jin-lu, Zhang, Yuan-yuan, Zhao, Qian, Zhu, Qing
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2014
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4016881/
https://ncbi.nlm.nih.gov/pubmed/24860834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/262385
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky